Boehringer Ingelheim to Pay $95 Million to Resolve False Claims Act Allegations

Published November 10, 2012

Boehringer Ingelheim to Pay Million to Resolve False Claims Act Allegations

Filed under: drug treatment programs washington dc

Washington, DC – Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $ 95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD …
Read more on Yumanewsnow

Jackie Lacey, Los Angeles County DA, Faces Tough Challenge In Realignment …

Filed under: drug treatment programs washington dc

Alternative sentencing courts give women, veterans, drug offenders and the mentally ill a chance to avoid a jail sentence by agreeing to receive substance abuse treatment and other services intended to keep them from going back to a life of crime …
Read more on Huffington Post

Lilly to Present Phase II to Treat Autoimmune Diseases; Celgene's ABRAXANE …

Filed under: drug treatment programs washington dc

10-14, 2012, in Washington, D.C. These compounds include tabalumab, an anti-BAFF monoclonal antibody, and baricitinib, a janus kinase (JAK) inhibitor being developed in partnership with Incyte Corporation. …. Verastem, Inc., (NASDAQ: VSTM)a clinical …
Read more on Equities.com